Syndax Pharmaceuticals Inc’s recently made public that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Syndax Pharmaceuticals
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0
Syndax Pharmaceuticals, Inc. (SNDX), a clinical-stage healthcare company that focuses on an HDAC inhibitor for tumors and specializes in cancer